Anton Haass

TL;DR: For patients with suspected stroke, treatment by the mobile stroke unit substantially reduced median time from alarm to therapy decision, and the MSU strategy offers a potential solution to the medical problem of the arrival of most stroke patients at the hospital too late for treatment.

TL;DR: It is recommended that all links in the prehospital stroke rescue chain must be optimised so that in the future more than a small minority of patients can profit from time-sensitive acute stroke therapy.

TL;DR: Withdrawal of an unfolded, fully recoverable, intracranial stent yielded very promising angiographic and clinical results and combines the advantages of prompt flow restoration and mechanical thrombectomy.

TL;DR: In the future, HES should be characterized by the in vivo, not the in vitro MW, because of the fact that HES with a high in vivo MW affects factor VIII/von Willebrand factor which can lead to an acquired vonWillebrand syndrome.

TL;DR: Initial post-market experience of the Penumbra system revealed that the revascularization rate and safety profile of the device are comparable to those reported in the Pivotal trial, however, the proportion of patients who had good functional outcome was higher than expected.